Quick Pulses of Full Conversation: Tachyons, Soundbites, Takeaways..
Diverse Interviews at MedTech Conference
We covered a huge amount of ground in two days, 17 interviews of some amazing companies, Randy. I mean, like Shiva Med, Sensai, Corvista, Verado Medical. Where else do we go? I mean, ResMed, Butterfly Network. Am I leaving out? I mean, there's 10 more to go. SPR Therapeutics, Hologic, Carl Storzs, Click Therapeutics, NanoWear, Rivana. Teladoc, Edwards. I think that's about all of them. I was 17. It was extremely productive and extremely exhausting. Yeah, no, it was. But what I loved about the curation of these interviews, they were handpicked, hand selected across the board, topical, high and, you know, really valued leaders in that from very early startups to ResMed, Hologic, publicly traded entities, Edwards, Life Sciences, et cetera.
Breakthrough Innovations in Med Tech
What were some takeaways that you gained? Yeah, so I can give you a couple of key summary points that I that I think span a number of the interviews. First of all, there is still a lot of white space in med tech. There are a lot of just new technologies coming out for diagnostics, monitoring, and therapeutic that are really breakthrough and powerful. And these are advances across biology, chemistry, physics, and then sort of silicon code, machine learning, AI data. And the combinations of these things is tremendous. So we talk to people with really interesting things going on Neurostimulation, digital therapeutics is such a cognitive behavioral change, especially in partnership with working in conjunction with pharmaceuticals. Ultrasound therapy, so using ultrasound to make changes in the body. In-vitro diagnostics augmented with artificial intelligence, so you have some kind of a tissue or some kind of a pathology sample in a lab that you're then putting together with AI. people doing interesting things with remote care, both primary care and digital surgery kind of things, remote surgery.
Regulatory Challenges and Industry Expectations
The bigger challenge people have is they complain about how am I going to get paid for it and the lack of clarity or the lack of innovation around that. So that's a pretty neat thing to see, you know, just that sort of broad satisfaction, I think, in general with the relationship between regulators and the companies they regulate in a highly regulated industry. You know, and I feel like you saying that, Randy, a lot of our conversations were with those regulatory experts. And, you know, we had the CEO, you know, co-founder, early founders that had a lot of years of experience. So everyone was so, you know, knowledgeable. And those interviews almost I see as, you know, such a informative way to understand the whole landscape as well. Yeah. Yeah. It's an exciting time. I think there's a lot of terrific things going on. Next 10 years promise to be very interesting and I think very rewarding to people in the industry and hopefully very healthy for the patients that we're serving.
AI Transforming Medical Devices
It shouldn't be a big shock, but Mark Andreessen said software is eating the world. Software is definitely eating medical devices. And if software is eating the world, AI is eating software. More and more of the value of medical devices is coming from software. And more and more of that value is coming specifically from AI machine learning. So there's just huge opportunities here. And I think everybody felt, people we talked to across R&D, clinical affairs, commercial, executive leadership, they all feel that like we're just at the very beginning of this process. So a lot of interesting trends.
Find us & follow us:
😍 💕 🌍 💜 😊 🚀Most important thing is to subscribe to keep updated with our latest podcasts, newsletters...etc.
Planetary Health First Mars Next is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
We might just lift off to Mars if the orbit is right! 😍 💕 🌍 💜 😊 🚀
In love & kindness,
Michael Mann, (😍 💕)
Disclaimer: the views of the participants are their own only and do not reflect the views of other participants, participants' organizations, etc or Planetary Health First Mars Next or the Host…….
This podcast is for informational purposes only and should not be considered professional or medical advice.
In addition if there are any mistakes or facts that need to be corrected please feel free to reach out to us so we can correct any statement.
Understand we are a self published entity and do the best we can.
If you have an idea or have an inspiring topic or know anyone that would be a great guest for our show please reach out to michael@planetaryhealthfirstmarsnext.org
132 The MedTech Conference in Toronto, Randy Horton Co-host, CSO with Orthogonal & Michael Mann